Generic Cerianna Availability
Last updated on May 7, 2025.
Cerianna is a brand name of fluoroestradiol F 18, approved by the FDA in the following formulation(s):
CERIANNA (fluoroestradiol f-18 - solution;intravenous)
-
Manufacturer: GE HEALTHCARE
Approval date: May 20, 2020
Strength(s): 50ML (4-100mCi/ML) [RLD]
Is there a generic version of Cerianna available?
No. There is currently no therapeutically equivalent version of Cerianna available in the United States.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cerianna. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
Related exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
Exclusivity expiration dates:
- May 20, 2025 - NEW CHEMICAL ENTITY
More about Cerianna (fluoroestradiol F 18)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: diagnostic radiopharmaceuticals
Patient resources
Professional resources
Related treatment guides
Related/similar drugs
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Gvoke
Gvoke is used subcutaneously to treat very low blood sugar (severe hypoglycemia) in people with ...
Flyrcado
Flyrcado (flurpiridaz F 18) is a radioactive diagnostic drug that may be used for positron emission ...
Fluciclovine F 18
Fluciclovine F 18 systemic is used for diagnosis and investigation, positron emission tomography imaging
Florbetaben f-18
Florbetaben f-18 systemic is used for positron emission tomography imaging
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.